Cenobamate, a new epilepsy drug was established as safe and effective with reduced seizure frequency and higher seizure-freedom rate. A post hoc analyses from an open-label study, including 240 adult participants found 73.8% retention rate and 25.8% seizure freedom for >12 months. 33.9% of those who continued taking cenobamate were seizure free for about 23.5 […]
Maximize the informational quality of your email inbox by selectively subscribing to evidence-based health and wellness resources that are informed by rigorous scientific research and medical expertise.
Your privacy is important to us
© 2020-2022 HealthSciaxis a Sciaxis Company. All rights reserved. Our website services, content, and products are for informational purposes only. HealthSciaxis does not provide medical advice, diagnosis, or treatment. See additional information.
